Thrombospondin 1 acts as a strong promoter of transforming growth factor effects via two distinct mechanisms in hepatic stellate cells
Open Access
- 1 May 2005
- Vol. 54 (5) , 673-681
- https://doi.org/10.1136/gut.2004.042911
Abstract
Background and aims: Thrombospondin 1 (TSP-1) is an important activator of latent transforming growth factor β (TGF-β) but little is known of the expression patterns and functions of TSP-1 in liver cells. We therefore analysed if and how TSP-1 acts on TGF-β during fibrogenesis. Methods and results: Using reverse transcription-polymerase chain reaction, we demonstrated that hepatocytes from normal liver expressed no TSP-1 mRNA whereas Kupffer cells and sinusoidal endothelial cells did. TSP-1 mRNA and protein were detected in quiescent and activated cultured hepatic stellate cells (HSC) and TSP-1 expression was highly inducible by platelet derived growth factor BB (PDGF-BB) and, to a lesser extent, by tumour necrosis factor α in activated HSC. Furthermore, addition of PDGF-BB directly led to enhanced TGF-β mRNA expression and a TSP-1 dependent increase in TGF-β/Smad signalling. Using either a peptide specifically blocking the interaction of TSP-1 with latent TGF-β or antibodies against TSP-1 not only abrogated activation of latent TGF-β but also reduced the effects of the active dimer itself. Conclusions: Our data suggest that TSP-1 expression is important for TGF-β effects and that it is regulated by the profibrogenic mediator PDGF-BB in HSC. Furthermore, the presence of TSP-1 seems to be a prerequisite for effective signal transduction by active TGF-β not only in rat HSC but also in other cell types such as human dermal fibroblasts.Keywords
This publication has 46 references indexed in Scilit:
- Expression of cytosolic and membrane associated tissue transglutaminase in rat hepatic stellate cells and its upregulation during transdifferentiation to myofibroblasts in cultureHepatology Research, 2004
- Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1American Journal of Physiology-Renal Physiology, 2004
- A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivoJournal of Hepatology, 2003
- Antisense‐mediated reduction in thrombospondin‐1 expression reduces cell motility in malignant glioma cellsInternational Journal of Cancer, 2001
- Expression and Matrix Deposition of Latent Transforming Growth Factor β Binding Proteins in Normal and Fibrotic Rat Liver and Transdifferentiating Hepatic Stellate Cells in CultureHepatology, 2001
- Increased Expression of Transforming Growth Factor-β1 and Thrombospondin-1 in Congenital Hepatic Fibrosis: Possible Role of the Hepatic Stellate CellJournal of Pediatric Gastroenterology and Nutrition, 1999
- Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cellsJournal of Hepatology, 1998
- Localization of Thrombospondin in Hepatocellular CarcinomaHepatology, 1997
- Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on cc14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-? in cocultures with sinusoidal endothelial cells*1Hepatology, 1995
- Insulinlike growth factor—ii/mannose 6-phosphate receptor is expressed on ccl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-β in cocultures with sinusoidal endothelial cellsHepatology, 1995